Andres Webersinke

Life/Health Chief Underwriting Officer, Head of Life/Health Research & Development, Cologne

Andres Webersinke is Gen Re’s Global Chief Underwriting Officer for Life/Health and Head of R&D, responsible for leadership in assessing individual risks and R&D activities. The R&D activities include Gen Re’s Business School, InsurTech co-operations, Underwriting Research & Rules Engine as well as Products & Analytics. During the course of his more than 25 years with Gen Re he has held various technical, marketing and management positions in Germany, South Africa, Singapore and Australia.

  • Krebserkennung durch Bluttest?

    By Andres Webersinke |Mar 05, 2018|Deutsch

    Das Jahr 2018 begann mit vielversprechenden Neuigkeiten zum Thema Krebs: Durch einen einfachen Bluttest können nun acht verschiedene Krebsarten erkannt werden. Der sogenannte CancerSEEK-Test wurde am Krebsforschungszentrum der Johns Hopkins University...

    Read More
  • A Blood Test Can’t Detect Cancer, Can It?

    By Andres Webersinke |Feb 06, 2018|English

    We began 2018 with some promising news on cancer: A simple blood test can now detect disease in eight common sites. Called the CancerSEEK test, it was developed at the Johns Hopkins Kimmel Cancer Center, and may herald a new age in cancer medicine. How...

    Read More
  • It’s Time to Future-Proof Your Data, Systems and Culture

    By Andres Webersinke |Sep 05, 2017|English

    The long-term prospects of most Life and Health insurers are going to be determined by their ability to transition from a product-based approach to a customer-centric value proposition. But, if they’re going to make that leap, insurers will have to know...

    Read More